Natco Pharma Q1 profit slumps 57% on lower Lenalidomide sales
Natco Pharma's consolidated net profit fell 57% year-on-year to Rs 206.5 crore in the June quarter, driven by lower sales of generic cancer drug Lenalidomide, The Hindu reports. Total revenue dropped 43%…
